2023. Genetic Polymorphism & Methotrexate Therapy Outcomes in Rheumatoid Arthritis. Precision Medicine Communications. 3, 1 (Jun. 2023), 05–09. DOI:https://doi.org/10.55627/pmc.003.01.0317.